Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post 5 Biggest Blockchain ETFs in 2025 next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Valeura Energy Inc. Announces Manora Drilling Exceeds Management’s... March 9, 2026 Rio Tinto Partners with Codelco to Develop Lithium... May 23, 2025 Crypto Market Recap: Stablecoin Market Makes Headway, SharpLink... June 14, 2025 Settlement of Tranche 1 Share Placement June 26, 2025 Top 5 Canadian Mining Stocks This Week: Carlton... September 6, 2025 Crypto Market Update: Altcoins Retreat as Bitcoin ETFs... October 11, 2025 Horn Island Project Update November 5, 2025 Chris Marcus: Silver Supply Crunch Not Over, Price... November 13, 2025 Theia Grade Control Confirms Geological Interpretation December 2, 2025 Top 5 Junior Gold Mining Stocks on the... July 8, 2025